Open an account

NU Skin Enterprises

NUS · NYSE

$4.98+$0.01 (+0.20%)TodayMarket closed ·
Prev close $4.97

About NUS

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. The company is headquartered in Provo, Utah and currently employs 2,800 full-time employees. The company has nine segments, consisting of its seven geographic Nu Skin segments - Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan - and two Rhyz segments - Manufacturing and Rhyz Other. Its brands include Nu Skin personal care, Pharmanex nutrition and ageLOC anti-aging. Its skin and beauty solutions include acne and blemishes, anti-aging, dark circles and puffiness, discoloration, dry skin, lifting and firming, lines and wrinkles, and oily skin and pores. Its nutrition solutions include bone and joint health, brain and memory, energy and stamina, heart health, immunity support, nail skin and hair health, and women's health. The company offers various beauty devices, including ageLOC Rose Gold LumiSpa iO, ageLOC LumiSpa Silicone Head, ageLOC LumiSpa iO Stand and LumiSpa Rose Gold Accent Twin Pack.

Employees
2,800
Headquarters
Provo, Utah
Listed
Nov 22, 1996
Sector
Consumer Staples
Industry
Personal Care Products
Website
nuskin.com

NUS key statistics

Market cap
242.41M
Price-earnings ratio
0.00
Dividend yield
4.75%
Average volume
480.58K
Volume
327.61K
Open price
$5.02
High today
$5.08
Low today
$4.97
52 Week high
$11.67
52 Week low
$4.45

NU Skin Enterprises (NUS) at a glance

As of Oct 20, 2026, NU Skin Enterprises (NUS) shares are priced at $4.98, giving the company a market cap of 242.41M, a price-to-earnings ratio of 0.00 and a dividend yield of 4.75%.

Today the stock has traded between $4.97 and $5.08. The current price is 0.2% above the day's low and 2.0% below its high.

Volume so far is 327.61K shares, below the average of 480.58K shares a day.

Over the past year NU Skin Enterprises has ranged from $4.45 to $11.67, and now sits 7% of the way up that range.

NU Skin Enterprises met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $0.20 per share against an estimate of $0.202.

NUS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 59.1% on average.

  1. Q3 FY24: reported $0.17 per share against an estimate of $0.1973
  2. Q4 FY24: reported $0.38 per share against an estimate of $0.2151
  3. Q1 FY25: reported $0.23 per share against an estimate of $0.1323
  4. Q2 FY25: reported $0.43 per share against an estimate of $0.2475
  5. Q3 FY25: reported $0.34 per share against an estimate of $0.303
  6. Q4 FY25: reported $0.29 per share against an estimate of $0.303
  7. Q1 FY26: reported $0.14 per share against an estimate of $0.1515
  8. Q2 FY26: reported $0.20 per share against an estimate of $0.202

NUS news

  • Press releaseBusiness Wire

    Nu Skin Ranked the World’s #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year

  • Press releaseBusiness Wire

    Nu Skin Enterprises Reports Second Quarter Results

  • Press releaseBusiness Wire

    Nu Skin Enterprises Announces Quarterly Dividend

  • Press releaseBusiness Wire

    Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition

  • Press releaseBusiness Wire

    Nu Skin Enterprises Reports First Quarter Results

  • Press releaseBusiness Wire

    Nu Skin Enterprises Announces Quarterly Dividend

  • Press releaseBusiness Wire

    Nu Skin Enterprises to Announce First Quarter 2026 Financial Results

Similar companies

Companies in the same industry as NU Skin Enterprises

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.